Jim's
rating on
this stock

STOCK
SYMBOL

Closing
price that
day

Full Company Name & Jim's Comments:

JNJ*

59.85

Johnson & Johnson (JNJ*)

[Caller indicated that her entire portfolio was in pharma stocks... ]

Jim:   You started out strong with JNJ*, which I own for ActionAlertsPlus.com, my charitable trust, which was down $2 today...  There was a valuation downgrade the other day.  Here's what I say...  I say that big pharma does not have nearly as much to fear from Obama.  It reminds me of 1992, when Clinton came in...  I feel that we are in better shape than we realize.  Here's what I want you to do.  I want you to take all of those... all of them... sell, sell, sell!... sell them all, and roll them into JNJ* so you are no longer just a medicine chest, but an actual diversified investor.

NOK

16.12

Nokia (NOK)

Jim:   Why?  Why?  Because of the dividend?  Maybe you get in long because of the dividend?  I don't see any earnings momentum there...  I have to tell you, the dividend is safe... I feel that the cell phone industry is going to be challenged for a while.  NOK is the best of breed, but the question I have is, why be in anything related to cell phones?   Let's check with  Skyworks Solutions (SWKS) tomorrow when they report. That will give us a better look at NOK.

TMO

40.17

Thermo Fisher Scientific, Inc. (TMO)

Jim:   In this environment, as I have said many, many times since we got to the September 19th call to sell 20% of your portfolio... if it doesn't have a big yield... if it isn't trading near its cash... or if it isn't anti... if it isn't recession-resistant, we don't want to own it.  TMO qualifies for recession-resistant, however, this is a company that makes medical equipment for companies that don't have any problem paying for it, like biotech... so I want to own the stock.  Would I pull the trigger right here?  We've got to let the market come down a little...  Maybe between the Dow 8,500 and 8,000.  Until then, don't buy more of it...  don't buy, don't buy...  I do like the company though.